EUVIMEDEUVIMED entdecken
Crossref

P54 COMPARING THE RISK OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS BETWEEN GABAPENTINOIDS AND DULOXETINE

Mina Yakoub, Daniela Moga, Chris Delcher, Meredith Duncan, Val Adams, Matthew Duprey

Value in Health · 2026-06 · 29 (6) · S17

DOI: 10.1016/j.jval.2026.03.082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Value in Health, 2026-06. Verfasst von Mina Yakoub und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Yakoub, M., Moga, D., Delcher, C., Duncan, M., Adams, V., & Duprey, M. (2026). P54 COMPARING THE RISK OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS BETWEEN GABAPENTINOIDS AND DULOXETINE. Value in Health, 29(6), S17. https://doi.org/10.1016/j.jval.2026.03.082

Vancouver

Yakoub M, Moga D, Delcher C, Duncan M, Adams V, Duprey M. P54 COMPARING THE RISK OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS BETWEEN GABAPENTINOIDS AND DULOXETINE. Value in Health. 2026;29(6):S17. doi:10.1016/j.jval.2026.03.082

BibTeX
@article{Yakoub2026,
  author = {Yakoub, Mina and Moga, Daniela and Delcher, Chris and Duncan, Meredith and Adams, Val and Duprey, Matthew},
  title = {P54 COMPARING THE RISK OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS BETWEEN GABAPENTINOIDS AND DULOXETINE},
  journal = {Value in Health},
  year = {2026},
  volume = {29},
  number = {6},
  pages = {S17},
  doi = {10.1016/j.jval.2026.03.082}
}
Kostenlos starten →